Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Neuroprotective Potential of Biflavone Ginkgetin: A Review (CROSBI ID 321665)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Çankaya, İ. İrem Tatlı ; Devkota, Hari Prasad ; Zengin, Gokhan ; Šamec, Dunja Neuroprotective Potential of Biflavone Ginkgetin: A Review // Life, 13 (2023), 2; 562, 17. doi: 10.3390/life13020562

Podaci o odgovornosti

Çankaya, İ. İrem Tatlı ; Devkota, Hari Prasad ; Zengin, Gokhan ; Šamec, Dunja

engleski

Neuroprotective Potential of Biflavone Ginkgetin: A Review

Neurological disorders are becoming more common, and there is an intense search for molecules that can help treat them. Several natural components, especially those from the flavonoid group, have shown promising results. Ginkgetin is the first known biflavonoid, a flavonoid dimer isolated from ginkgo (Ginkgo biloba L.). Later, its occurrence was discovered in more than 20 different plant species, most of which are known for their use in traditional medicine. Herein we have summarized the data on the neuroprotective potential of ginkgetin. There is evidence of protection against neuronal damage caused by ischemic strokes, neurotumors, Alzheimer’s disease (AD), and Parkinson’s disease (PD). Beneficial effects in ischemic strokes have been demonstrated in animal studies in which injection of ginkgetin before or after onset of the stoke showed protection from neuronal damage. AD protection has been the most studied to date. Possible mechanisms include inhibition of reactive oxygen species, inhibition of β-secretase, inhibition of Aβ fibril formation, amelioration of inflammation, and antimicrobial activity. Ginkgetin has also shown positive effects on the relief of PD symptoms in animal studies. Most of the available data are from in vitro or in vivo animal studies, where ginkgetin showed promising results, and further clinical studies should be conducted.

Alzheimer’s disease ; biflavonoids ; ginkgetin ; neuroprotection ; ginkgo

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

13 (2)

2023.

562

17

objavljeno

2075-1729

10.3390/life13020562

Povezanost rada

Biologija, Biotehnologija

Poveznice